Circulating tumor cells: A review of Non-EpCAM-based approaches for cell enrichment and isolation

Clinical Chemistry

Volumn 62, Issue 4, 2016, Pages 571-581

  Gabriel, Marta Tellez ^a,b   Calleja, Lidia Rodriguez ^a,b   Chalopin, Antoine ^a,b,c   Ory, Benjamin ^a,b   Heymann, Dominique ^a,b,c,d  

^a Universite de Nantes   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; CELL ADHESION MOLECULE; EPCAM PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

ANALYTIC METHOD; ANTIBODY AFFINITY; CELL ENRICHMENT METHOD; CELL ISOLATION; CENTRIFUGATION; CIRCULATING TUMOR CELL; DENSITY GRADIENT CENTRIFUGATION; ELECTROPHORESIS; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; MAGNETIC SEPARATION; MICROFILTRATION; MICROFLUIDICS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; BLOOD; CELL SEPARATION; CHEMISTRY; METABOLISM; SINGLE CELL ANALYSIS; TUMOR EMBOLISM;

ANTIGENS, NEOPLASM; BIOMARKERS, TUMOR; CELL ADHESION MOLECULES; CELL SEPARATION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASTIC CELLS, CIRCULATING; SINGLE-CELL ANALYSIS;

EID: 84962381099     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2015.249706     Document Type: Review

References (75)

1. vandeStolpe A, Pantel K, Sleijfer S, Terstappen LW, den Toonder JM. Circulating tumor cell isolation and diagnostics: toward routine clinical use. Cancer Res 2011;71:5955-60.
2. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 2006;6:449-58.
3. McGee SF, Lanigan F, Gilligan E, Groner B. Mammary gland biology and breast cancer. Conference on Common Molecular Mechanisms of Mammary Gland Development and Breast Cancer Progression. EMBO Rep 2006;7:1084-8.
4. Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer 2009;9:302-12.
5. Lloyd JM, McIver CM, Stephenson SA, Hewett PJ, Rieger N, Hardingham JE. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells. Clin Cancer Res 2006;12:417-23.
6. Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008;13:58-68.
7. Pantel K, Speicher MR. The biology of circulating tumor cells. Oncogene [Epub ahead of print 2015 Jun 8].
8. Ghossein RA, Bhattacharya S, Rosai J. Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res 1999;5:1950-60.
9. Zhe X, Cher ML, Bonfil RD. Circulating tumor cells: finding the needle in the haystack. Am J Cancer Res 2011; 1:740-51.
10. Gorges TM, Pantel K. Circulating tumor cellsastherapy-related biomarkers in cancer patients. Cancer Immunol Immunother 2013;62:931-9.
11. Alix-Panabieres C, Pantel K. Challenges in circulating tumourcell research. Nat Rev Cancer 2014;14:623-31.
12. Alix-Panabieres C, Pierga JY. Circulating tumor cells: liquid biopsy. Bull Cancer 2014;101:17-23.
13. Patriarca C, Macchi RM, Marschner AK, Mellstedt H. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review. Cancer Treat Rev 2012;38:68-75.
14. Hardingham JE, Kotasek D, Farmer B, Butler RN, Mi JX, Sage RE, Dobrovic A. Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res, 1993;53:3455-8.
15. Liljefors M, Nilsson B, Fagerberg J, Ragnhammar P, Mellstedt H, Frödin JE. Clinical effects of a chimeric anti-EpCAM monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor in patients with metastatic colorectal carcinoma. Int J Oncol 2005;26:1581-9.
16. Andreopoulou E, Yang LY, Rangel KM, Reuben JM, Hsu L, Krishnamurthy S, Valero V, et al. Comparisonofassay methods for detection of circulating tumor cells inmetastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect versus Veridex CellSearch system. Int J Cancer 2011;130:1590-7.
17. Hofman V, Ilie MI, Long E, Selva E, Bonnetaud C, Molina T, et al. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay and the isolation by size of epithelial tumor cell method. Int J Cancer 2011;129: 1651-60.
18. Pantel K, Denève E, Nocca D, Coffy A, Vendrell JP, Maudelonde T, et al. Circulating epithelial cells in patients with benign colon diseases. Clin Chem 2012;58: 936-40.
19. Mikolajczyk SD, Millar LS, Tsinberg P, Coutts SM, Zomorrodi M, Pham T, et al. Detection of EpCAM-negative and cytokeratin-negative circulating tumor cells in peripheral blood. J Oncol 2011;2011:252361.
20. Bobek V, Gurlich R, Eliasova P, Kolostova K. Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation. World J Gastroenterol 2014;20: 17163-70.
21. Low WS, Wan Abas WA. Benchtop technologies for circulating tumor cells separation based on biophysical properties. Biomed Res Int 2015;2015:239362.
22. Jacob K, Sollier C, Jabado N, Circulating tumor cells: detection, molecular profiling and future prospects. Expert Rev Proteomics 2007;4:741-56.
23. PöselC, Möller K, Fröhlich W, Schulz I, Boltze J, Wagner DC. Density gradient centrifugation compromisesbone marrow mononuclear cell yield. PLoS One 2012;7: e50293.
24. Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C, et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A 2012;109:3879-84.
25. Chang Y, Hsieh PH, Chao CC. The efficiency of Percoll and Ficoll density gradient media in the isolation of marrow derived human mesenchymal stem cells with osteogenic potential. Chang Gung Med J 2009;32: 264-75.
26. Rosenberg R, Fuehrer K, Dahm M, Nekarda H, Siewert JR. Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. Recent Results Cancer Res 2003;162:149-55.
27. Rosenberg R, Gertler R, Friederichs J, Fuehrer K, Dahm M, Phelps R, et al. Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry 2002;49: 150-8.
28. Gerges N, Rak J, Jabado N. New technologies for the detection of circulating tumour cells. Br Med Bull 2010; 94:49-64.
29. Danova M, Torchio M, Mazzini G. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications. Expert Rev Mol Diagn 2011; 11:473-85.
30. Zabaglo L, Ormerod MG, Parton M, Ring A, Smith IE, Dowsett M. Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells. Cytometry A 2003;55:102-8.
31. Shiau JS, Tang CHI, Lin TY, Wang DM. Amodel for resistance growth during protein microfiltration. Sep Sci Technol 2003;38:917-32.
32. Zheng S, Lin HK, Lu B, Williams A, Datar R, Cote RJ, Tai YC. 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood. Biomed Microdevices 2011;13:203-13.
33. Lu B, Xu T, Goldkorn A, Tai YC. Parylene membrane slot filter for the capture, analysis and culture of viable circulating tumor cells. Proceedings of the 23rd IEEE International Conference on Micro Electro Mechanical Systems (MEMS '10), Hong Kong, China. Jan 25-28 2010;935-8.
34. Lin HK, Zheng S, Williams AJ, Balic M, Groshen S, Scher HI. Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin Cancer Res 2010;16:5011-8.
35. Desitter I, Guerrouahen BS, Benali-Furet N, Wechsler J, Jänne PA, Kuang Y, et al. A new device for rapid isolation by size and characterization of rare circulating tumor cells. Anticancer Res 2011;31:427-41.
36. Freidin MB, Tay A, Freydina DV, Chudasama D, Nicholson AG, Rice A, et al. An assessment of diagnostic performance of a filter-based antibody-independent peripheral blood circulating tumour cell capture paired with cytomorphologic criteria for the diagnosis of cancer. Lung Cancer 2014;85:182-5.
37. Mohamed H, McCurdy LD, Szarowski DH, Duva S, Turner JN, Caggana M. Development of a rare cell fractionation device: application for cancer detection. IEEE Trans Nanobioscience 2004;3:251-6.
38. Tan SJ, Yobas L, Lee GY, Ong CN, Lim CT. Microdevice for the isolation and enumeration of cancer cells from blood. Biomed Microdevices 2009;11:883-92.
39. Xu L, Mao X, Imrali A, Syed F, Mutsvangwa K, Berney D, et al. Optimization and evaluationofa novel size based circulating tumor cell isolation system. PLoS One 2015; 10:e0138032.
40. Wu A, Bhagat AA, Leong MC, Lim CT. ClearCell FX: a microfluidic system for label-free circulating tumor cell enrichment. J Clin Oncol 2014;32(15 Suppl):e22023.
41. Karabacak NM, Spuhler PS, Fachin F, Lim EJ, Pai V, Ozkumur E, et al. Microfluidic, marker-free isolation of circulating tumor cells from blood samples. Nat Protoc 2014;9:694-710.
42. Pohl HA. Some effects of nonuniform fields on dielectrics. J Appl Phys 1958;29:1182-8.
43. Pethig R. Review article-dielectrophoresis: status of the theory, technology, and applications. Biomicrofluidics 2010;4:022811.
44. Gonzalez CF, Remcho VT. Harnessing dielectric forces for separations of cells, fine particles and macromole-cules. J Chromatogr A 2005;1079:59-68.
45. Becker FF, Wang XB, Huang Y, Pethig R, Vykoukal J, Gascoyne P. Separation of human breast cancer cells from blood by differential dielectric affinity. Proc Natl Acad Sci U S A 1995;92:860-4.
46. Moon HS, Kwon K, Kim SI, Han H, Sohn J, Lee S, Jung HI. Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP). Lab Chip 2011; 11:1118-25.
47. Gupta V, Jafferji I, Garza M, Melnikova VO, Hasegawa DK, Pethig R, Davis DW. ApoStream(™), a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood. Biomicrofluidics 2012;6:24133.
48. Bolognesi C, Doffini A, Busson G, Lanzellotto, Signorini G, Sero V et al. Image-based microchip sorting of pure, immuno-phenotyically defined subpopulation of tumor cells from tiny formalin-fixed paraffin embedded (FFPE) samples reveals their distinct genetic features. Cancer Res 2015;75:1552.
49. Vykoukal J, Vykoukal DM, Freyberg S, Alt EU, Gascoyne PR. Enrichment of putative stem cells from adipose tissue using dielectrophoretic field-flow fractionation. Lab Chip 2008;8:1386-93.
50. Moldenhauer G, Momburg F, Möller P, Schwartz R, Hämmerling GJ. Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. Br J Cancer 1987;56:714-21.
51. Deng G, Herrler M, Burgess D, Manna E, Krag D, Burke JF. Enrichmentwith anti-cytokeratin alone orcombined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in meta-static breast cancer patients. Breast Cancer Res 2008; 10:R69.
52. Pamme N. On-chip bioanalysis with magnetic particles. Curr Opin Chem Biol 2012;16:436-43.
53. Talasaz AH, Powell AA, Huber DE, Berbee JG, Roh KH, Yu W, et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc Natl Acad Sci USA 2009;106:3970-5.
54. Ghazani AA, McDermott S, Pectasides M, Sebas M, Mino-Kenudson M, Lee H, et al. Comparison of select cancer biomarkers in human circulating and bulk tumor cells using magnetic nanoparticles and a miniaturized micro-NMR system. Nanomedicine 2013;9: 1009-17.
55. Haun JB, Devaraj NK, Hilderbrand SA, Lee H, Weissleder R. Bioorthogonal chemistry amplifies nano-particle binding and enhances the sensitivity of cell detection. Nat Nanotechnol 2010;5:660-5.
56. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW, Uhr JW. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 1998;95:4589-94.
57. Schneider T, Moore LR, Jing Y, Haam S, Williams PS, Fleischman AJ, et al. Continuous flow magnetic cell fractionation based on antigen expression level. J Biochem Biophys Methods 2006;68:1-21.
58. Zborowski M, Chalmers JJ. Rare cell separation and analysis by magnetic sorting. Anal Chem 2011;83: 8050-6.
59. O'Hara SM, Moreno JG, Zweitzig DR, Gross S, Gomella LG, Terstappen LW. Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer. Clin Chem 2004;50:826-35.
60. Zigeuner RE, Riesenberg R, Pohla H, Hofstetter A, Oberneder R. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro. J Urol 2003;169:701-5.
61. Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A, Deng G, et al. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One 2012;7:e33788.
62. Pamme N. Magnetism and microfluidics. Lab Chip 2006;6:24-38.
63. Hoshino K, Huang YY, Lane N, Huebschman M, Uhr JW, Frenkel EP, Zhang X. Microchip-based immunomagnetic detection of circulating tumor cells. Lab Chip 2011;11:3449-57.
64. Lu J, Fan T, Zhao Q, Zeng W, Zaslavsky E, Chen JJ, et al. Isolation of circulating epithelial and tumor progenitor cells with aninvasive phenotype from breast cancer patients. Int J Cancer 2010;126:669-83.
65. Fan T, Zhao Q, Chen JJ, Chen WT, Pearl ML. Clinical significance of circulating tumor cells detected by an invasion assayinperipheral bloodofpatients with ovarian cancer. Gynecol Oncol 2009;112:185-91.
66. Zheng X, Cheung LS, Schroeder JA, Jiang L, Zohar Y. A high-performance microsystem for isolating circulating tumor cells. Lab Chip 2011;11:3269-76.
67. Adams AA, Okagbare PI, Feng J, Hupert ML, Patterson D, Göttert J, et al. Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor. J Am Chem Soc 2008;130:8633-41.
68. Hughes AD, Mattison J, Western LT, Powderly JD, Greene BT, King MR. Microtube device for selectin-mediated capture ofviable circulating tumor cells from blood. Clin Chem 2012;58:846-53.
69. Auman JT, McLeod HL. Colorectal cancer cell lines lack the molecular heterogeneity of clinical colorectal tumors. Clin Colorectal Cancer 2010;9:40-7.
70. Cayrefourcq L, Mazard T, Joosse S, Solassol J, Ramos J, Assenat E, et al. Establishment and characterization of a cell line from human circulating coloncancercells. Cancer Res 2015;75:892-901.
71. Yu M, Bardia A, Aceto N, Bersani F, Madden MW, Donaldson MC, et al. Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 2014;345:216-20.
72. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339:580-4.
73. Yokobori T, Iinuma H, Shimamura T, Imoto S, Sugimachi K, Ishii H, et al. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelialmesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res 2013;73:2059-69.
74. Lustberg MB, Balasubramanian P, Miller B, GarciaVilla A, Deighan C, Wu Y, et al. Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients. Breast Cancer Res 2014;16:R23.
75. Adams DL, Martin SS, Alpaugh RK, Charpentier M, Tsai S, Bergan RC et al. Circulating giant macrophages as a potential biomarker of solid tumors. Proc Natl Acad Sci U S A 2014;111:3514-9.